GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » ROE %

Health Catalyst (Health Catalyst) ROE % : -32.36% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Health Catalyst's annualized net income for the quarter that ended in Dec. 2023 was $-121.2 Mil. Health Catalyst's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $374.7 Mil. Therefore, Health Catalyst's annualized ROE % for the quarter that ended in Dec. 2023 was -32.36%.

The historical rank and industry rank for Health Catalyst's ROE % or its related term are showing as below:

HCAT' s ROE % Range Over the Past 10 Years
Min: -48.25   Med: -34.12   Max: -29.02
Current: -30

During the past 7 years, Health Catalyst's highest ROE % was -29.02%. The lowest was -48.25%. And the median was -34.12%.

HCAT's ROE % is ranked worse than
80.69% of 611 companies
in the Healthcare Providers & Services industry
Industry Median: 4.12 vs HCAT: -30.00

Health Catalyst ROE % Historical Data

The historical data trend for Health Catalyst's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Catalyst ROE % Chart

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial - -48.25 -38.39 -29.02 -29.84

Health Catalyst Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.09 -31.98 -32.82 -22.82 -32.36

Competitive Comparison of Health Catalyst's ROE %

For the Health Information Services subindustry, Health Catalyst's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's ROE % distribution charts can be found below:

* The bar in red indicates where Health Catalyst's ROE % falls into.



Health Catalyst ROE % Calculation

Health Catalyst's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-118.147/( (425.01+366.919)/ 2 )
=-118.147/395.9645
=-29.84 %

Health Catalyst's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-121.248/( (382.394+366.919)/ 2 )
=-121.248/374.6565
=-32.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Health Catalyst  (NAS:HCAT) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-121.248/374.6565
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-121.248 / 300.336)*(300.336 / 707.367)*(707.367 / 374.6565)
=Net Margin %*Asset Turnover*Equity Multiplier
=-40.37 %*0.4246*1.888
=ROA %*Equity Multiplier
=-17.14 %*1.888
=-32.36 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-121.248/374.6565
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-121.248 / -120.676) * (-120.676 / -131.14) * (-131.14 / 300.336) * (300.336 / 707.367) * (707.367 / 374.6565)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0047 * 0.9202 * -43.66 % * 0.4246 * 1.888
=-32.36 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Health Catalyst ROE % Related Terms

Thank you for viewing the detailed overview of Health Catalyst's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Catalyst (Health Catalyst) Business Description

Traded in Other Exchanges
Address
10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Executives
Linda Llewelyn officer: Chief People Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Jason Alger officer: Chief Accounting Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Benjamin Landry officer: General Counsel C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Matthew Kolb director C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt officer: Chief Financial Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton director, officer: Chief Executive Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore officer: COO and Chief Product Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Kevin Lee Freeman officer: Chief Growth Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein officer: General Counsel 311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier officer: Chief Operating Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton officer: Chief Technology Officer C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr. officer: Chief Financial Officer C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121

Health Catalyst (Health Catalyst) Headlines